C

concept-medical

lightning_bolt Market Research

Company Profile: Concept Medical



Background



Overview

Concept Medical is a research-oriented organization specializing in the development of innovative medical devices for the treatment of cardiovascular and peripheral interventional diseases. Established in 2008, the company is headquartered in Tampa, Florida, and operates globally, with a commercial presence in over 80 countries.

Mission and Vision

The company's mission is to "convert concepts into reality," focusing on delivering medical devices that address unmet clinical needs in the cardiovascular and peripheral interventional fields. This vision drives their commitment to advancing healthcare through cutting-edge technology and patient-centric solutions.

Primary Area of Focus

Concept Medical specializes in Drug Eluting Stents (DES) and Drug Coated Balloons (DCB), utilizing proprietary nanotechnology-based drug delivery systems to treat coronary and peripheral artery diseases. Their products aim to improve patient outcomes by enhancing the efficacy and safety of vascular interventions.

Industry Significance

As a leader in the development of advanced vascular medical devices, Concept Medical plays a pivotal role in addressing the global burden of cardiovascular diseases. Their innovative approach to drug delivery technology has set new standards in vascular therapy, impacting millions of patients worldwide.

Key Strategic Focus



Core Objectives

  • Innovation in Drug Delivery: Developing advanced drug-eluting technologies to improve the effectiveness of vascular interventions.

  • Global Expansion: Extending their reach to over 80 countries to provide innovative solutions to a broader patient population.

  • Clinical Validation: Conducting extensive clinical trials to ensure the safety and efficacy of their products.


Specific Areas of Specialization

  • Drug Eluting Stents (DES): Stents that release pharmaceutical agents to prevent artery re-narrowing.

  • Drug Coated Balloons (DCB): Balloon catheters coated with drugs to treat arterial blockages without leaving permanent implants.


Key Technologies Utilized

  • Nanotechnology-Based Drug Delivery Systems: Employing nanocarrier-based platforms to enhance drug delivery precision and effectiveness.

  • Polymer-Free Nanocarrier-Based Platforms: Utilizing novel drug delivery systems that do not rely on polymers, aiming to reduce complications associated with polymer-based devices.


Primary Markets Targeted

  • Cardiovascular Disease Treatment: Addressing coronary artery diseases through innovative vascular interventions.

  • Peripheral Artery Disease Treatment: Providing solutions for peripheral artery diseases to improve blood flow and reduce complications.


Financials and Funding



Funding History

Concept Medical has raised a total of $60 million in funding, with the most recent round occurring seven years ago.

Notable Investors

Dr. Kiran C. Patel is a notable investor in Concept Medical.

Utilization of Capital

The capital raised has been utilized to support research and development initiatives, expand manufacturing capabilities, and facilitate global market expansion.

Pipeline Development



Key Pipeline Candidates

  • MagicTouch Sirolimus Coated Balloons (SCBs): A family of SCBs recognized for their versatility and efficacy in treating coronary and peripheral artery diseases.


Stages of Development

  • Clinical Trials: Ongoing clinical trials to validate the safety and efficacy of their products.


Target Conditions

  • Coronary Artery Disease: Aiming to prevent artery re-narrowing post-angioplasty.

  • Peripheral Artery Disease: Addressing arterial blockages to improve blood flow.


Anticipated Milestones

  • Regulatory Approvals: Seeking approvals in various international markets to expand product availability.

  • Market Launches: Planning to introduce new products to meet diverse patient needs.


Technological Platform and Innovation



Proprietary Technologies

  • Nanocarrier-Based Drug Delivery Systems: Innovative platforms that enhance the precision and effectiveness of drug delivery in vascular interventions.


Significant Scientific Methods

  • Nanotechnology Applications: Utilizing nanotechnology to develop advanced drug-eluting devices.

  • Polymer-Free Drug Delivery Systems: Developing drug delivery systems that do not rely on polymers, aiming to reduce complications associated with polymer-based devices.


Leadership Team



Key Executives

  • Dr. Kiran C. Patel: Investor and key supporter of Concept Medical.


Professional Backgrounds

  • Dr. Kiran C. Patel: A prominent figure in the healthcare industry, known for his contributions to medical innovation and support for emerging medical technologies.


Key Contributions

  • Investment and Support: Providing financial backing and strategic guidance to advance Concept Medical's mission.


Competitor Profile



Market Insights and Dynamics

  • Market Size and Growth Potential: The global market for drug-eluting devices is substantial, with a growing demand for innovative solutions in vascular interventions.

  • Industry Trends: There is an increasing focus on minimally invasive procedures and advanced drug delivery technologies to improve patient outcomes.


Competitor Analysis

  • Boston Scientific: A leading competitor in the medical device industry, offering a range of vascular intervention products.

  • Orchestra BioMed: Specializes in developing and commercializing medical devices with a focus on vascular diseases.

  • Penumbra: Provides innovative medical devices for neuro and peripheral vascular conditions.


Strategic Collaborations and Partnerships

  • Scientific Advisory Board: Collaborates with leading cardiovascular experts to ensure clinical validation and credibility of their products.


Operational Insights

  • Competitive Advantages: Proprietary nanotechnology-based drug delivery systems and a strong focus on research and development.

  • Market Position: Recognized as a leader in the development of advanced vascular medical devices.


Strategic Opportunities and Future Directions

  • Global Expansion: Entering new international markets to provide innovative solutions to a broader patient population.

  • Product Diversification: Developing new products to address a wider range of cardiovascular and peripheral diseases.


Contact Information



  • Official Website: Concept Medical website available upon inquiry.

  • LinkedIn: Concept Medical company profile available upon inquiry.

Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI